Results 261 to 270 of about 66,837 (311)
Some of the next articles are maybe not open access.
Scope economies in the pharmaceutical sector
Rivista Internazionale di Scienze Economiche e Commerciali, 2006The paper’s objectives are twofold: to propose an experimental simulation to measure scope economies between pairs of submarkets and to point out the role of submarkets in explaining the concentration level in the pharmaceutical market. We simulate scope economies consistent with the diversification choices of large international companies in the years
openaire +2 more sources
The pharmaceuticals sector in Vietnam
2016The fundamental goal of competition law is to support productivity and innovativeness; in fact, the short-term effect of enforcement actions is often a reduction in product prices. This book reports the findings of consumer market studies into a range of goods and services in developing countries in Africa, Asia and Latin America.
Que Anh Pham, Tran Phuong Lan
openaire +1 more source
Blockchain in Pharmaceutical Sector
2020The pharmaceutical research and development is a composite process that grabs lots of years in drug discovery, drug development and regulatory approval in the supply chain in the pharmaceutical sector. But due to the drugs counterfeiting, such as hidden, uncontrolled and outdated information of drug regulatory authority and manufacturers over drugs ...
Meet Kumari, Meenu Gupta, Chetanya Ved
openaire +1 more source
Monopoly in the pharmaceutical sector
Pharmaceuticals Policy and Law, 2010Almost every EU country has a form of regulation for the pharmaceutical sector, the level of which varies by country, motivated by the unique nature of medicine as a consumers good, different from any other good. In the majority of EU countries this circumstance allows the monopoly of the profession to extend to the dispensing of all medicine subject ...
openaire +1 more source
Innovation, competition, and the pharmaceutical sector: theory and practice
Journal of European Competition Law & PracticeWith high-technology markets coming increasingly under scrutiny from a competition law perspective, scholars and institutions have increasingly highlighted the relevance of innovation-related considerations in competition law analyses.Fortunately, there is a rich theoretical debate on the innovation-competition relationship, in particular by Smith ...
Jacquelyn Veraldi, Alicja Sołtykowska
openaire +1 more source
Archivum Immunologiae et Therapiae Experimentalis, 2010
The pharmaceutical sector is a part of today's economy in which the relationship between patents and competition has been receiving increasing attention. The European Commission's inquiry into this sector adds to the ongoing debate. Its Preliminary Report, published in November 2008, explains and quantifies a number of practices adopted by individual ...
openaire +2 more sources
The pharmaceutical sector is a part of today's economy in which the relationship between patents and competition has been receiving increasing attention. The European Commission's inquiry into this sector adds to the ongoing debate. Its Preliminary Report, published in November 2008, explains and quantifies a number of practices adopted by individual ...
openaire +2 more sources
Public subsidies for R&D and public sector pharmaceutical innovation
Applied Economics, 2021Dimitrios Kourouklis
exaly
Abuse of Dominance in the EU Pharmaceutical Sector
SSRN Electronic JournalThis article is a comprehensive review of European Union and national level public enforcement actions in the pharmaceutical sector from 1974 to 2022. Whereas this research demonstrates that competition authorities are increasingly using competition law as a tool to hold pharmaceutical companies accountable in the pursuit of access to medicines goals ...
openaire +2 more sources